New Pill Approved for Schizophrenia, Bipolar Disorder

(MedPage Today) — The FDA approved milsaperidone (Bysanti) tablets as first-line therapy for adults with schizophrenia and manic or mixed episodes related to bipolar I disorder, Vanda Pharmaceuticals announced on Friday.
Milsaperidone is an active…